Skip to main content
. 2022 Jul 22;9:925389. doi: 10.3389/fmolb.2022.925389

FIGURE 4.

FIGURE 4

Clinical applications of circRNAs in thyroid cancer. CircRNAs are extracted from cell, blood, biopsy and exosome from TC patients. RNA sequencing, microarray, single-cell RNA-seq, quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) assays are methods that can be used to detect circRNA levels. CircRNAs are significantly associated with many clinicopathologic characteristics of TC and with TC patient survival parameters, rendering them potential diagnostic and prognostic biomarkers for TC. Overexpression or knockdown of target circRNAs resulting from delivery may serve as potential therapeutic approaches for TC.